GuangYuYuan Chinese Herbal Medicine Co., Ltd.

XSSC:600771 Stock Report

Market Cap: CN¥9.5b

GuangYuYuan Chinese Herbal Medicine Past Earnings Performance

Past criteria checks 2/6

GuangYuYuan Chinese Herbal Medicine's earnings have been declining at an average annual rate of -21.4%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 1.6% per year. GuangYuYuan Chinese Herbal Medicine's return on equity is 5%, and it has net margins of 5.8%.

Key information

-21.4%

Earnings growth rate

-20.9%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate1.6%
Return on equity5.0%
Net Margin5.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How GuangYuYuan Chinese Herbal Medicine makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSSC:600771 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,2076973135
30 Jun 241,2509775433
31 Mar 241,24110471132
31 Dec 231,2849076131
30 Sep 231,280-10994234
30 Jun 231,345-2051,01833
31 Mar 231,279-2301,00432
31 Dec 221,131-25090429
30 Sep 221,081-25589026
30 Jun 22958-26084825
31 Mar 22902-31485727
31 Dec 21854-31684125
30 Sep 211,017-14477838
30 Jun 211,052-6073240
31 Mar 211,0751069941
31 Dec 201,1093271143
30 Sep 201,0502170655
30 Jun 201,1085669861
31 Mar 201,17110068157
31 Dec 191,21713069463
30 Sep 191,45132264363
30 Jun 191,50534768161
31 Mar 191,59738073267
31 Dec 181,61937475858
30 Sep 181,45335970854
30 Jun 181,32030268447
31 Mar 181,26126467835
31 Dec 171,16923763131
30 Sep 171,0541815955
30 Jun 171,0441805750
31 Mar 179491395310
31 Dec 169371235310
30 Sep 16773464710
30 Jun 16622233910
31 Mar 16534113450
31 Dec 1542822930
30 Sep 15369362810
30 Jun 15395343010
31 Mar 15380442840
31 Dec 14354372700
30 Sep 14341-192660
30 Jun 14300-252380
31 Mar 14254-292330
31 Dec 13268-202190

Quality Earnings: 600771 has high quality earnings.

Growing Profit Margin: 600771 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 600771's earnings have declined by 21.4% per year over the past 5 years.

Accelerating Growth: 600771 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 600771 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-2.5%).

Return on Equity

High ROE: 600771's Return on Equity (5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:32
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GuangYuYuan Chinese Herbal Medicine Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Min QiuChina Merchants Securities Co. Ltd.
Zhouyu DengGuosen Securities Co., Ltd.